|
|
Thomson Financial Business Description:
| The Company's principal activities are researching, developing and commercialising biotechnological treatments through its proprietary technology platforms. It focuses in identifying and developing therapies for cancer treatment and Central Nervous System conditions, which includes anxiety, Multiple Sclerosis and epilepsy. Other processes include identifying particular genes or proteins that may prove to have a role in the onset or the progression of diseases, particularly epilepsy, breast cancer and pathologies associated with angiogenesis. It has 2 proprietary platforms, ionX and Angene, that are used in validating these genes and proteins as drug targets. It operates solely in Australia. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Bionomics Limited
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
